Cumberland Pharmaceuticals Inc.
CPIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,480 | -$6,279 | -$5,650 | -$3,603 |
| Dep. & Amort. | $6,043 | $5,770 | $5,328 | $4,606 |
| Deferred Tax | $0 | $0 | $0 | -$193 |
| Stock-Based Comp. | $302 | $365 | $448 | $742 |
| Change in WC | $1,293 | $4,635 | $10,972 | $8,180 |
| Other Non-Cash | -$1,771 | $1,603 | -$2,644 | -$3,390 |
| Operating Cash Flow | -$612 | $6,094 | $8,453 | $6,342 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$180 | -$453 | -$2,074 | -$354 |
| Net Acquisitions | $0 | $0 | -$13,500 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$200 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $238 | $347 | $1,899 | $53 |
| Investing Cash Flow | $58 | -$106 | -$13,674 | -$502 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,492 | -$3,416 | $1,200 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$579 | -$741 | -$1,053 | -$1,387 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,716 | -$3,268 | -$2,209 | -$2,167 |
| Financing Cash Flow | $197 | -$7,424 | -$2,062 | -$3,554 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$357 | -$1,436 | -$7,283 | $2,287 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,322 | $19,758 | $27,041 | $24,754 |
| End Cash | $17,964 | $18,322 | $19,758 | $27,041 |
| Free Cash Flow | -$792 | $5,641 | $6,380 | $5,988 |